Paper30723593
Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.
Yaddanapudi K and 7 others. Oncoimmunology, 2019. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention. Papers, record 30723593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30723593
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 CA106599 | NCI NIH HHS | United States | K01CA106599 | PubMed and NIH | NIH RePORTER |
| P20 RR018733 | NCRR NIH HHS | United States | P20RR018733 | PubMed | NIH RePORTER |
| R01 AA018016 | NIAAA NIH HHS | United States | R01AA018016 | PubMed and NIH | NIH RePORTER |
| P30 GM106396 | NIGMS NIH HHS | United States | P30GM106396 | PubMed and NIH | NIH RePORTER |
| R21 CA198249 | NCI NIH HHS | United States | R21CA198249 | PubMed and NIH | NIH RePORTER |
| R01 CA175003 | NCI NIH HHS | United States | R01CA175003 | PubMed and NIH | NIH RePORTER |
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10545503 | Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. | J Cell Biol | 1999 | https://conductscience.org/library/papers/10545503 | PubMed |
| 2 | 11897870 | Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. | Stem Cells | 2002 | https://conductscience.org/library/papers/11897870 | PubMed |
| 3 | 11900993 | GM-CSF-based cellular vaccines: a review of the clinical experience. | Cytokine Growth Factor Rev | 2002 | https://conductscience.org/library/papers/11900993 | PubMed |
| 4 | 12154376 | Exosomes: composition, biogenesis and function. | Nat Rev Immunol | 2002 | https://conductscience.org/library/papers/12154376 | PubMed |
| 5 | 12445288 | GM-CSF-based cancer vaccines. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12445288 | PubMed |
| 6 | 12771702 | Tumor markers in the diagnosis of primary bladder cancer. A systematic review. | J Urol | 2003 | https://conductscience.org/library/papers/12771702 | PubMed |
| 7 | 12947071 | Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12947071 | PubMed |
| 8 | 14595124 | Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. | Stem Cells | 2003 | https://conductscience.org/library/papers/14595124 | PubMed |
| 9 | 16557261 | Regulatory T cells, tumour immunity and immunotherapy. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16557261 | PubMed |
| 10 | 16796806 | Prospects for exosomes in immunotherapy of cancer. | J Cell Mol Med | 2006 | https://conductscience.org/library/papers/16796806 | PubMed |
| 11 | 16860657 | Cancer vaccines: preclinical studies and novel strategies. | Adv Cancer Res | 2006 | https://conductscience.org/library/papers/16860657 | PubMed |
| 12 | 17486113 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. | Nat Cell Biol | 2007 | https://conductscience.org/library/papers/17486113 | PubMed |
| 13 | 17577033 | Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17577033 | PubMed |
| 14 | 18375791 | Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. | Blood | 2008 | https://conductscience.org/library/papers/18375791 | PubMed |
| 15 | 18443585 | An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. | Nat Genet | 2008 | https://conductscience.org/library/papers/18443585 | PubMed |
| 16 | 19171137 | Embryonic vaccines against cancer: an early history. | Exp Mol Pathol | 2009 | https://conductscience.org/library/papers/19171137 | PubMed |
| 17 | 19319200 | Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. | PLoS One | 2009 | https://conductscience.org/library/papers/19319200 | PubMed |
| 18 | 19816950 | Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer. | Stem Cells | 2009 | https://conductscience.org/library/papers/19816950 | PubMed |
| 19 | 19898981 | GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/19898981 | PubMed |
| 20 | 20512124 | An autoimmune-mediated strategy for prophylactic breast cancer vaccination. | Nat Med | 2010 | https://conductscience.org/library/papers/20512124 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41843206 | Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/41843206 | PubMed |
| 41809263 | Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress. | Asian J Pharm Sci | 2025 | https://conductscience.org/library/papers/41809263 | PubMed |
| 41256221 | Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms. | Small Sci | 2025 | https://conductscience.org/library/papers/41256221 | PubMed |
| 41131419 | Biomedical applications of extracellular vesicles (EVs): even better with cryogels. | Mikrochim Acta | 2025 | https://conductscience.org/library/papers/41131419 | PubMed |
| 40843170 | Engineered exosomes: a promising design platform for overcoming cancer therapy resistance. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40843170 | PubMed |
| 40532508 | Biodistribution studies of 89Zr-Labeled stem cell-derived exosomes using PET imaging. | Appl Radiat Isot | 2025 | https://conductscience.org/library/papers/40532508 | PubMed |
| 40475972 | Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine. | Burns Trauma | 2025 | https://conductscience.org/library/papers/40475972 | PubMed |
| 40160248 | Engineered extracellular vesicles as imaging biomarkers and therapeutic applications for urological diseases. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40160248 | PubMed |
| 39739089 | The efficacy of an embryonic stem cell-based vaccine for lung cancer prevention depends on the undifferentiated state of the stem cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/39739089 | PubMed |
| 39591185 | Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39591185 | PubMed |
| 39483807 | Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics. | J Extracell Biol | 2024 | https://conductscience.org/library/papers/39483807 | PubMed |
| 39040921 | Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy. | Research (Wash D C) | 2024 | https://conductscience.org/library/papers/39040921 | PubMed |
| 38098229 | Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity. | Mol Ther | 2024 | https://conductscience.org/library/papers/38098229 | PubMed |
| 37365450 | The therapeutic potential of exosomes in lung cancer. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/37365450 | PubMed |
| 37048091 | Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes. | Cells | 2023 | https://conductscience.org/library/papers/37048091 | PubMed |
| 36860847 | Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. | Front Immunol | 2023 | https://conductscience.org/library/papers/36860847 | PubMed |
| 36742283 | Exosome-based cancer vaccine for prevention of lung cancer. | Stem Cell Investig | 2023 | https://conductscience.org/library/papers/36742283 | PubMed |
| 36727049 | Exosomes and cancer immunotherapy: A review of recent cancer research. | Front Oncol | 2022 | https://conductscience.org/library/papers/36727049 | PubMed |
| 35915054 | Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35915054 | PubMed |
| 34842232 | Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells. | J Vis Exp | 2021 | https://conductscience.org/library/papers/34842232 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30723593
GET https://conductscience.org/api/papers/v1/30723593/references?page=2